体内连续进化新体系提高D-阿洛酮糖3-差向异构酶转化率的分子机制
批准号:
32101884
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘展志
依托单位:
学科分类:
食品生物化学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘展志
中文摘要
D-阿洛酮糖因热量低且口感与蔗糖类似等优势备受瞩目,其制造用酶D-阿洛酮糖3-差向异构酶(DPEase)对原料D-果糖转化率却一直未能突破33%,致使成本居高不下。前期研究中,我们挖掘出该制造壁垒的理论根源在于DPEase结合D-果糖这种非生理性底物时呈现“葫芦”形构象,大尺度偏离经典酶锁钥模型,不仅直接导致转化率低,亦对分子改造提升酶功能提出极大挑战。为攻克上述难题,我们跳出实验室定向进化局限,创制基因突变和酶性能筛选偶联于同一生物体的新体系。本项目拟阐明“靶向可控触发突变【变得多】、信号转导承接偶联【联得紧】、程序死亡驱动筛选【选得准】”的DPEase体内连续进化分子基础,揭示DPEase底物转化率提升的酶学机制并获得转化率显著提升的突变体,攻克D-阿洛酮糖制备壁垒。本项目不仅对推动D-阿洛酮糖降低成本面向大众消费具有积极意义,而且对于发展酶分子改造新理论新技术亦具有重要参考价值。
英文摘要
D-psicose has attracted great attention due to its low calorie and similar taste to sucrose, the conversion rate of raw material D-fructose by its manufacturing enzyme, D-psicose 3-epimerase (DPEase), has not been broken through 33%, resulting in the high cost of D-psicose. In previous studies, we found that the theoretical root of this manufacturing barrier was that DPEase exhibited a "gourd"-shaped conformation when bounded with non-physiological substrate D-fructose, and deviated from the classic enzyme lock-and-key model on a large scale, which not only directly leads to extremely low conversion rate, but also poses great challenges to molecular modification for enzyme function enhancement. In order to overcome the above-mentioned problems, we have broken away from the limitation of laboratory-directed evolution and created a new system coupling gene mutation and enzyme performance screening in vivo. This project aims to clarify the molecular basis of DPEase continuous evolution in vivo: controllable targeting-triggered mutation for broad diversity, signal transduction-undertaken coupling for tight linkage, programmed death-driven screening for accurate selection, reveal the enzymatic mechanism for enhancement of DPEase substrate conversion, and obtain mutants with significantly increased conversion rate, so as to overcome the barrier of D-psicose manufacturing. This project not only has positive significance for reducing the cost for mass consumption, but also has important reference value for the development of new theory and technology of enzyme molecular modification.
本项目针对D-阿洛酮糖制备关键酶D-阿洛酮糖3-差向异构酶(DPEase)催化效率低这一核心问题,建立了首个特异性体内连续进化系统PEACE,成功实现了DPEase的高效分子改造。通过挖掘并改造新型胞苷脱氨酶CDA1L1_4a,显著提升了靶向突变模块的突变效率,并设计目的基因双向启动子,实现了目的酶突变和翻译的双稳态控制。基于转录因子PsiR构建并优化了D-阿洛酮糖响应型生物传感器,并结合具有双重筛选标准的程序致死筛选模块,实现了菌株-酶活力的精准传感及其超高通量筛选。进一步通过基于生物传感器的连续进化与超高通量筛选,最终获得了兼具高比活力和优异热稳定性的叠加突变体H207L/D281G/C289R。该突变体将D-果糖转化率从21.64%提升至29.39%,并将反应平衡时间从4小时缩短至2小时。构效关系解析表明,H207L/D281G/C289R突变体通过优化亚基界面盐桥网络和表面电荷分布,显著提升了热稳定性和催化效率。此外,通过半理性设计改造启动子碳分解代谢阻遏元件(CRE)区域,有效缓解了枯草芽孢杆菌碳分解代谢阻遏(CCR)效应,其中CRE区域突变体T6A在低浓度碳源条件下的发酵酶活提升至对照组的297.7%。最终实现了上述优势突变体在枯草芽孢杆菌中的高效表达,发酵酶活达到4971.50 U·mL⁻¹,为目前报道的最高水平。本研究不仅突破了D-阿洛酮糖制备的技术瓶颈,还为工业酶分子改造提供了新理论和新技术,推动了D-阿洛酮糖低成本绿色制造的进程。
基于人工设计与自驱动连续迭代进化策略的高产唾液酸乳糖微生物细胞工厂构建及其分子机制研究
-
批准号:22578168
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:刘展志
-
依托单位:
国内基金
海外基金